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INTRODUCTION 
 
Coronary artery disease is a relatively common and 
asymptomatic disease in type 2 diabetic patients. hence the diagnosis of 
coronary artery disease is difficult in initial phase of disease. 
This gained special attention over recent years, Since it has 
significant morbidity and mortality and coronary artery disease is one 
among the most common cause of death in diabetic individuals with 
mortality rate of 60 to 70 %.  
The incidence of type 2 diabetes is increasing all over the world 
and becoming a pandemic. But India remains the biggest contributor to 
global community.  
 
TYPE 2 DM & CAD  
In type 2 diabetic patients CAD constitutes major determining 
factor of morbidity and mortality. It is two times more common in 
diabetic patients than general population. Surprisingly two third of 
patients who develop acute myocardial infarction or   any other 
cardiovascular complications after 40 years of age have either diabetes  
mellitus or impaired glucose tolerance.  
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 CAD in diabetes is basically asymptomatic and silent during 
initial phase of disease and unmasking the risk of CAD has got 
paramount importance in modern day world since it prevents death and 
disability. Dyslipidemia plays the important role in both type 2 diabetes  
and CAD.  
             Even though CAD commonly associated with systemic 
hypertension, type 2 diabetes, stroke, obesity, smoking and lipid 
abnormalities   are still the most common associations.  
Prevalence of CAD has been reported as 8% in general population. 
CAD prevalence and incidence varies in different continents. Its 
prevalence increasing in India. Compared with non diabetic patients, 
people with diabetes have an increased incidence of CAD.  
Recent studies showed that CAD is independently associated with 
an increased HbA1c levels and mortality rates are higher in type 2 
diabetic patients with CAD than with general population. Patients with 
type 2 diabetes with CAD have got  poor prognosis.  
The screening  of CAD should be done early in  course of type 2 
diabetic patients, since diabetes itself is a cad equivalent. The patients 
with age more than 40 years should be subjected to screening tests for 
early diagnosis and timely intervention. 
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  The risk of CAD is highly dependent on associated cardiovascular  
risk factors in patients with diabetes such as hypertension, dyslipidemia, 
microvascular complications,  smoking, advanced age and family history 
of CAD.  
Silent myocardial ischemia  occurs in greater than one in five 
asymptomatic patients with type 2 diabetes.  
Diabetes is one of the main risk factors for coronary 
atherosclerosis since it accelerates its progression, causes endothelial 
dysfunction and increases platelets activity. 
Recent clinical trials have demonstrated the various markers for 
prediction of CAD in diabetic populations such as micro albuminuria, 
glycosylated haemoglobin(HbA1c),  high   sensitivity C-reactive protein 
(HsCRP) and other parameters. 
These laboratory parameters now in  emerging field of medicine 
and various clinical trials have been conducted to prove their role in 
screening and early diagnosis of CAD in diabetes patients.  
“Diabetes increases the risk of CAD by two to four folds and  
Myocardial ischemia is a major complication in the course of diabetes, 
causing 75% of diabetes-related deaths. Moreover, patients with  diabetes 
have a higher rate of sudden death and poorer outcomes after myocardial 
infarction.” 
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HIGH SENSITIVITY C-REACTIVE PROTEIN(HSCRP) 
A marker of systemic inflammation and  is  emerging as an 
independent risk factor for cardiovascular disease. High hsCRP levels 
have been attributed to the increased risk of thrombotic episodes 
including myocardial infarction.  
 “C-reactive protein (CRP) is a member belonging to pentraxin 
family of proteins. It is an acute phase reactant and synthesized by the 
liver. Serum levels are elevated in a response to acute infections, 
inflammations and trauma. In those clinical situations, the serum CRP 
levels increase rapidly generally beyond 10 mg/l with a concomitant 
elevation of erythrocyte sedimentation rates (ESR)12. CRP has a 
relatively long half-life of 18 to 20 h, owing to its stable pentraxin 
structure. In addition, CRP levels are stable as these do not exhibit 
diurnal variations or variations in relation to food intake. In the past 
decade, high-sensitivity assays with rapid turnaround times for 
measurement have become available. High-sensitivity assay techniques 
such as immunonephelometry, immunoturbidimetry, high-sensitivity 
enzyme-linked immunosorbent assay (ELISA) and resonant acoustic 
profiling (RAP) can detect CRP with a sensitivity range of 0.01 to 10 mg/ 
l13. These high-sensitivity assays help quantify low grades of systemic 
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inflammation, in the absence of overt systemic inflammatory or 
immunologic disorders.” 
Elevated hsCRP levels have also been linked to an increased risk 
of future development of diabetes. Furthermore, hsCRP levels are 
increased in people with diabetes compared with those non diabetes.  So 
far Studies have conducted on hscrp recommends that (hsCRP) is an 
significant biomarker for  prediction of global cardiovascular risk .  
The hsCRP has been noted to have opsonizing properties, 
increasing the recruitment of monocytes into atheromatous plaque and 
also inducing endothelial dysfunction by suppressing basal and induced 
nitric oxide release. The hsCRP per se has also been found to increase 
the expression of vascular endothelial plasminogen activator inhibitor-1 
(PAI-1) and other adhesion molecules and alter LDL uptake by 
macrophages11. However, interventions that directly inhibit hsCRP would 
have to be evaluated before conclusively establishing hsCRP as a direct 
contributor to the atherosclerotic process. 
On the basis of data obtained from population based studies, the 
AHA/CDC (American Heart Association/Centres for Disease Control) 
Working Group on markers of inflammation in CVD has classified serum 
hsCRP levels <1, 1–3 and >3 mg/l as low-, intermediate-, and high-risk 
groups for global CVD, respectively. 
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INCIDENCE OF CAD AROUND THE WORLD 
The national contribution  of Coronary artery disease caused by 
diabetes is increasing at  unprecedented rate. Currently type 2  diabetes  
mellitus patients affects 35million  people in the United States. Its 
prevalence is two times  more  than  in the past  few decades. Current 
estimation projects an incidence between one in five and one in three 
Americans by 2050.  
ETIOLOGY  
Etiology is multifactorial and many aspects still remains unknown..  
Environmental factors play major role in etiology. 
  Changing dietary habits and sedentary life style makes CAD to 
occur prematurely..    
PATHOGENESIS  
1. Chronic endothelial injury and dysfunction  
2. Deposition of lipoproteins – mainly LDL and VLDL and its 
oxidized products.  
3. Monocyte adhesion – immigration and macrophage formation – 
foam cell  
4.  Migration of smooth muscle cells to tunica intima  from media by 
factors released from platelets and macrophages.  
5.  Proliferation of smooth muscle cells . 
7 
 
6. Lipid accumulation.  
 MAJOR RISK FACTORS FOR  ATHEROMA  
1. Age (men > 45 years; women > 55 years).  
2.  Physical inactivity and Sedentary lifestyle.   
3. Systemic Hypertension ( patients with BP ≥140/90 mmHg or   taking  
drugs)  
4. Diabetes mellitus  
5. Obesity  with BMI ≥25 kg/m2. 
6. Decreased HDL level   [<40 mg/dL])  
7. Impaired glucose tolerance  
8. High levels of  LDL cholesterol.  
9. Tobacco  smoking . 
10.Positive family  history of premature ASCVD .   
12.High cholesterol diet    
 13.Lipoprotein (a).  
14.Prothrombotic & pro inflammatory factor 
15.Subclinical atherosclerosis  
  HDL  cholesterol    (≥60  mg/dL)  has  a  negative 
 association  with atherogenesis.  
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AIMS  AND  OBJECTIVES 
 
 To study the prevalence of asymptomatic coronary artery 
disease in type 2 diabetic mellitus patients by  Tread Mill 
TEST(TMT). 
 To evaluate the positive correlation between TMT positive 
patients and raised hsCRP levels in asymptomatic diabetics 
population.  
 To improve the long term survival in type2 diabetic    patients 
by early detection of  asymptomatic CAD and timely 
intervention.  
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REVIEW OF LITERATURE 
DEFINITION –DIABETES MELLITUS  
It’s group of metabolic disorders that share the phenotype of 
hyperglycemia  due to decreased production of insulin or developing 
resistance to its action. Absolute or relative deficiency of insulin results 
from interaction between  both genetic and environmental factors.  
Approximately diabetes is present in 3 to 5% of rural population in 
India. In urban  constitutes about 10 to 15%. NIDDM constitutes nearly 
95-97% of total diabetic population. The maximum macrovascular and 
microvascular complications are associated with NIDDM. 75% diabetic 
deaths mainly due to macrovascular complications.  
AGE AND SEX DISTRIBUTION  
Coronary artery disease, stroke and  peripheral vascular disease  are 
approximately 2 times more common  in men with diabetes mellitus than 
non diabetics. Compared with men women have 3 to 4 fold  risk of 
cardiac complications associated with type 2 diabetes .  
Age plays a major role for the occurrence  of vascular 
complications of  diabetes mellitus and prevalence of CAD increases as 
age advances. 
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Primary pathogenesis is formation of atheromatous plaque due to 
dyslipidemia. The incidence of atherosclerosis increases as the age 
advances and finally  leads to occlusion of blood vessels producing  
macrovascular complications.  
 
CRITERIA FOR DIAGNOSIS OF DIABETES  
• Symptoms –polyuria ,polydypsia, fatigue, hunger  plus random blood 
sugar     
 Concentration ≥11.1 mmol/L (200 mg/dL) or  
• Fasting plasma sugar ≥7.0 mmol/L (126 mg/dL) or  
• Hemoglobin A1c ≥ 6.5%c or  
 2-h plasma glucose ≥11.1 mmol/L (200 mg/dL) during an       
oral glucose tolerance test. 
 
CRITERIA FOR DIAGNOSING DIABETES ACCORDING TO 
ADA  
FPG ≥126 mg/dL.  
(Fasting is defined as there should not be caloric intake for at least 8h.) 
OR 
 2-h plasma glucose ≥200 mg/dL during an OGTT test. The test should 
be performed as described by the WHO, done with  75 g anhydrous   
glucose mixed with water.  
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OR   
Glycosylated hb(HbA1C) ≥6.5% . The test should be done using a 
method that is NGSP certified and standardized according  to the DCCT 
trial.* OR Patients with classical symptoms of hyperglycemia or 
hyperglycemic crisis, a  
Random plasma sugar ≥200 mg/dL .*  
*In the absence of unequivocal hyperglycemia, results should be 
confirmed by repeat testing.  
**Only diagnostic when patient with classic symptoms of hyperglycemia  
 
ETIOPATHOGENESIS  
             Type 2 diabetes  has strong genetic component .the incidence of 
type2 diabetes  in identical twins is  70 to 90% and it proves the single 
most causative factor.  
Individuals with a parent with diabetes have an increased risk and 
if both parents have type 2 diabetes ,the risk reaches 40%.  
            The genotype is altered by various factors, and the predominant  
factor will be central obesity. obesity per se will not  produce diabetes  
but it accelerates the disease in vulnerable group.  
  Obesity particularly central obesity present in older people 
contributes to the development of diabetes. 
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Studies showed that significant contribution from other life style 
events like smoking, lock of physical activity, dietary hobbits, 
consumption of highly refined carbohydrates, reduced intake of fibre diet 
and urbanization with stressful life in the development of type 2 diabetes.  
The current understanding of type 2 diabetes is probably heterogenous 
which involves abnormalities in the formation of  
1. Inadequate insulin production.  
2. Peripheral resistance to  action  of insulin. 
3. Increased hepatic glucose output  
The classical profile of type 2 diabetes consists of increased  
basal and fasting sugar levels upon which post prandial 
glycemic excursions are superimposed. The increased glucose 
output from liver is the principal factor for increased fasting and 
postprandial hyperglycemia in major part is determined by the 
peripheral glucose utilization  
  
CLASSIFICATION OF DIABETES 
Generally classified into  
1. Diabetes mellitus type 1.   
2. Diabetes mellitus type2  
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3. Gestational diabetes mellitus (GDM) (diabetes diagnosed     
    only  during Pregnancy  without overt diabetes)  
4. Monogenic diabetes syndromes (e.g.MODY   
    conditions of the exocrine pancreas (e.g., cystic fibrosis), or    
    drug- induced or chemical-induced diabetes (e.g. patients on    
    HIV/AIDS or  post  transplantation treatment)  
  
DIABETES RELATED COMPLICATIONS  
MACRO VASCULAR  
1. CEREBROVASCULAR DISEASE  
2. CORONARY ARTERY DISEASE  
3. PHERIPHERAL VASCULAR DISEASE   
  
 MICRO VASCULAR  
1. DIABETIC EYE DISEASE 
2. MACULAR EDEMA  
3. RETINOPATHY.  
 
  NEUROPATHY              
1. Autonomic.  
2. Sensory and motor (mono- and polyneuropathy).  
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NEPHROPATHY  
1. Albuminuria  
2. Declining renal function  
 
    OTHERS  
1. Dermatologic  
2. Gastrointestinal (gastroparesis, diarrhea)  
3. Genitourinary ( uropathy /sexual dysfunction)  
4. Hearing loss   
5. Cataracts  
6. Chorio arthropathy  
7. Glaucoma  
8. Osteoporosis  
9. Depression  
10. Periodontal disease  
11. Obstructive sleep apnea   
12. Fatty liver disease  
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ACUTE COMPLICATIONS OF DIABETES MELLITUS 
              1.DKA  
•  Absolute or relative  insulin deficiency  
• Counter regulatory hormone excess.  
             2. Hyperglycemic Hyperosmolar state (HHS)  
• Inadequate fluid intake.  
• Relative insulin deficiency  
Compared with DKA, patients with HHS has lower levels of counter   
regulatory hormones.  
  
CRITERIA  -  TESTING  FOR  DIABETES  OR  
PREDIABETES  IN   ASYMPTOMATIC ADULTS.  
   1.Test performed  in  adults with  BMI ≥25 kg/m2 or ≥23 kg/m2 
in Asians,  Americans with  risk factors like  
• Sedentary life style with physical inactivity.  
• First -degree  relatives . 
• High-risk race (e.g. Asian Americans,   African American, Native 
Americans) . 
• Women giving  birth with weight of a baby  >9 lb or  diagnosed as  
diabetes during   Pregnancy.  
• Systemic hypertension (≥140/90 mmHg or on treatment).  
• Triglyceride level of >250 mg/dl or HDL  level of <40 mg/dL.  
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• History of cardiovascular disease.  
• IGT,  IFG , glycosylated hemoglobin ≥5.7%  
• Patients with peripheral signs of  insulin resistance like Acanthosis  
nigricans , obesity.  
• PCOS  
2. Testing must be done at the age of 45  for all patients.  
3. Testing should be repeated at an interval of 3-years if results  are 
normal.       Further testing is advised depending on initial  and risk   
status.  
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COMPONENTS OF THE  DIABETES   MEDICAL EVALUATION  
 HISTORY  
• Age  of onset  (e.g. any History of DKA, previous  laboratory results) . 
• Nutrition status,   weight , life style  and behaviour.  
• Presence of associated comorbidities and  psychosocial factors . 
• Any substance abuse,  consumption of alcohol and tobacco smoking.  
• Previous  history of  treatment   and treatment  response. 
• Frequency and  severity of  episodes of DKA.   
• Awareness  and frequency  of previous  episodes of  hypoglycemia   
•  History of increased blood pressure, dyslipidemia and smoking 
•  Microvascular complications:  Nephropathy ,neuropathy and  
retinopathy.  
• Macrovascular complications: CAD, CVA and PVD  
  
VITALS  
• weight, Height and Body Mass Index(BMI). 
• Blood Pressure measurement  with orthostatic hypotension.  
• Examination of fundus. 
• Thyroid examination.  
•  Skin examinations  ( acanthosis nigricans,   insulin injection sites).  
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COMPREHENSIVE   FOOT   EXAMINATION  
1. Inspection.  
2.  Peripheral  arterial pulse examination.  
3. Examination of deep tendon reflexes.  
4. Test for monofilament & posterior colomn sensation examination.    
  
LAB PARAMETERS  
• HbA1C  
• If not done for the past 1 year  
1. Fasting lipid profile  
2. Liver function Test  
3. Spot Albumin creatinine Ratio.  
4. Serum creatinine and GFR.  
5. Women after the age of 50 years.   
  
   GOALS  FOR TREATMENT OF  ADULTS  WITH DIABETES  
   Glycemic control  
 Glycosylated hb(HbA1C)                            - <7.0%c  
 Preprandial capillary plasma sugar              - 80–130 mg/dL  
 Peak post prandial capillary plasma  
          Glucose                                            - <180 mg/dL  
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 Blood pressure                                              - <140/90 mmHg  
Lipid levels.  
 LDL                                      -  100 mg/dL.  
 HDL                                      -  40 mg/dL in men . 
                                                         -  50 mg/dL women.  
 Triglycerides                         -  150 mg/dL.  
  
RECOMMENDATIONS  FOR HbA1C  
• Its  advised that  HbA1C should be done  at least  twice  annually. 
• Quarterly  test is advised for  HbA1C  in patients  who are  having 
poor glycemic control.  
• Use of frequent testing for HbA1C provides the opportunity  for     
timely  intervention. 
   
HbA1C GOALS  
According to 2016 ADA Standards  for pregnant women.  
‘RECOMMENDATIONS  
• HbA1C   <7%  for  Non pregnant adults .  
• More strict  HbA1C  goals   less than 6.5% for  individual       
patients   (achieved   without   hypoglycaemia  )  
21 
 
• Less stringent  HbA1C goals ( < 8%   for  patients with           
advanced microvascular or macrovascular   complications, severe 
hypoglycemia,       other  co morbid illnesses or long duration of 
diabetes  ,     timely monitoring  of  glucose, and effective 
treatment of      multiple  oral glucose-  lowering agents.  
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RECOMMENDATIONS  
• An  Hb A1C goal of <7.5%  is recommended for children.   
      The benefit of HbA1C control should be balanced against the  risk of 
hypoglycemia .  
  
NUTRITIONAL   & PHYSICAL ACTIVITY  BEHAVIOURS  
RECOMMENDED  BY 2013 ACC/AHA  
  
 PATIENTS    are advised to:   
“Consume a dietary pattern that recommends the intake of fruit, 
vegetables  and whole grains; include  dairy products,  fish,  non tropical 
vegetable oils, poultry products  and nuts; and to limit the intake of 
sodium,  sugar-sweetened beverages, and red meats”  
“Adapting this dietary pattern for appropriate calorie requirements 
along with personal and cultural food preferences with nutrition therapy 
for other medical conditions (including diabetes mellitus).”  
• Achieve strict hypertensive goal   by  DASH diet ,  USFDA Food 
Pattern,  AHA Diet.  
• Engage in 2 hour and 30 minutes a week of moderate-intensity or 1 
h and 15 min  (75 min) a week of vigorous   aerobic physical exercise.  
24 
 
          An equivalent combination of moderate- and vigorous-intensity   
aerobic exercise . Aerobic exercise   should be performed in episodes of 
at least 10 min, preferably    should be done  throughout the week.  
  
RECOMMENDATIONS   OF STATIN THERAPY  
 High intensity statin therapy 
 Lowers the cholesterol by >_ 50%. 
Atorvastatin 40-80 mg 
Rosuvastatin 20 to 40 mg 
Moderate intensity statin therapy 
reduces the cholesterol by 30% to 50% 
Rosuvastatiin  5-10mg  
Atorvastatin 10 -20 mg              
Pravastatin 40 -80mg  
Lovastatin 40 mg 
Simvastatin 20-40 mg 
Fluvastatin XL 80mg 
Pitavastatin 80 mg 
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SUMMARY  OF  THE  FOUR  STATIN  BENEFIT GROUPS   
ACCORDING  TO  ACC/AHA  
• Clinical Atherosclerotic vascular disease  for “secondary prevention”  
• LDL-Cholesterol ≥190 mg/dL without  any secondary cause.   
• Primary prevention - Diabetes mellitus: age range between  40–75 
years,    
   LDL-C  70–189  mg/dL  
 Primary prevention Nondiabetics : age between 40–75  years  and  
LDL- cholesterol between 70–189 mg/dL, 
           estimated ASCVD risk ≥7.5% 
    
         INSULIN  RESISTANCE  AND  METABOLIC SYNDROME  
  
Type 2 diabetes mellitus patients  die mainly because  of 
Cardiovascular disease and its complications.  Aging  and   obesity are 
the  reason for  epidemic of type 2 diabetes mellitus. “The dyslipidemia  
which is associated with insulin resistance  called  as Diabetic 
Dyslipidemia, accounts for the increased Cardiovascular risk in patients 
with type 2 diabetes ”.  
           Generally  diabetic patients having normal LDL cholesterol levels 
But those are small and dense atherogenic LDL particles .Diabetic 
dyslipidemia have lipid profile of  reduced HDL cholesterol  and 
increased triglyceride  levels.  
26 
 
TREAD MILL TEST 
  
DEFINITION  
 “defined as  a stress test done by doing bicycle exercise with monitoring 
of electrocardiography (ECG) and Blood pressure. 
 
USES OF STRESS TEST IMAGING  
1. .Basically  used as a diagnostic procedure.  
2. Cardiovascular stress induced by pharmacotherapy  and is 
demonstrated in    patients with  reduced  functional capacity of  
heart. 
3. Indiduals  with decreased exercise tolerance , the  dobutamine    
induced stress  testing  can  be done  along  with  other       imaging 
modalities like   echocardiography..  
  
USES OF TREAD MILL TESTING.  
1. Exercise stress testing is  offordable at  low cost.  
2. Used to assess the  functional Capacity  & prognosis.    
3. Used    to assess the extent and  probability  of  coronary artery 
disease.  
4. Used to assess the therapeutic effects.   
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Arterial Blood Gas analysis, Echocardiography, radionuclide 
imaging  can give further         information.  In  moderate or prior risk of 
CAD , it can be       used as an additional evidence factor .  
       Tread mill  stress test along   with electrocardiogrphy  was 
considered  as one of the important points in the diagnosis as well as 
prognosis of CVD particularly(CAD).  
         Henry Ford   Exercise Testing   indicates  that an inverse 
relationship between cardio- respiratory fitness and  incidental AF, for  
those who are obese .  
  
EXERCISE PHYSIOLOGY  
 “The initiation of dynamic exercise results in increases in 
ventricular heart rate, stroke volume, and cardiac output. It is due to vagal 
withdrawal and sympathetic stimulation. Alveolar ventilation and venous 
return   increase   due to sympathetic vasoconstriction. The hemodynamic 
response depends on amount of muscle tension involved, exercise 
efficiency & intensity, conditioning”.  
 “ In the initial phases of exercise in the upright position, cardiac 
output is increased by an increase in stroke volume. Stroke volume  
mediated by  the Frank Starling  mechanism and heart rate.” 
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           “ The increase in cardiac output in the later phases of exercise is 
due to  elevated ventricular rate. During vigorous  exercise, there is 
maximal sympathetic discharge. During exercise parasympathetic 
stimulation is withdrawn. resulting in auto  regulation with generalized 
vaso constriction. It occurs in all except in the vital organs like  coronary 
and cerebral circulations.”              
 Norepinephrine release from sympathetic post ganglionic   nerve   
endings    is increased.  Epinephrine levels are elevated at peak exertion. 
It results in a rise in ventricular contraction. As exercise continues, blood 
flow to skeletal muscle increases. Oxygen extraction increases to  3 fold;  
Followed by decrease in peripheral resistance. Mean arterial pressure, 
systolic blood pressure (SBP),   and pulse pressure usually increases. 
Diastolic blood pressure (DBP)   remains   unchanged .Sometimes  it  
may  oscillate  within 10 mm Hg.  
The pulmonary circulation can adopt   a 6 fold   increase in cardiac 
output. But   with no or slight increase in pulmonary arterial pressure, 
PCWP, and right atrial pressure. Its  is not a limiting determinant  of peak 
exercise capacity in normal subjects.  
Peak  heart rate  ,cardiac output are decreased in older people 
mainly due to   reduced  adrenergic responsiveness.   
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PEAK  HEART RATE CALCULATION 
Maximum heart rate=220 –PATIENT AGE IN YEARS 
  
STANDARD DEVIATION   
 “The maximum heart rate  for predicted age group is useful for 
safety purposes. And   For estimating the adequacy of the exercise to 
evoke inducible. An individual  reaches 80% of the age predicted 
maximum   have to considered as a good test result.  An age predicted   
heart rate maximum of 90% or better is considered excellent. In the post 
exercise phase, hemo dynamics return to baseline within minutes after 
exercise is discontinued.”  
 “After the exercise the return of vagal stimulation is an important 
cardiac mechanism. It can  easily attained in  trained athletes.   it is  
usually blunted in   chronic congestive heart failure patients. vigerous 
physical work or   cardio- respiratory impairment may interfere with 
achievement of a steady state.  An oxygen deficit occurs during exercise. 
The   oxygen  debt  defined as  the “total oxygen uptake in excess of the 
resting oxygen uptake during the recovery period.”  
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MET TO STAGES OF PROTOCOL  
  
  
 CLINICALLY SIGNIFICANT   METABOLIC EQUALENTS   
FOR   MAXIMUM   EXERCISE  
“1 MET          Resting  
2 METs           Level walking at 3.2 kmph  
4 METs           Level walking at 6.4 kmph  
<5 METs         Poor prognosis,for basic activities daily    
10 METs         Prognosis with medical therapy as good as CABG  
13 METs         Excellent prognosis regardless of other exercise  
18 METs         Athletes with high level of endurance  
20 METs         Athletes at world class athletic performance”  
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INDICATIONS  AND CONTRAINDICATIONS  
1.  Indicated  mainly for  prognosis and diagnosis  of cardiovascular 
disease, that is  coronary artery disease..   
2. TMT is the first  procedure of choice in patients having no 
abnormality in ECG  or near normal  ECG   during rest who are 
capable of doing adequate exercise.  
ABSOLUTE COTRAINDICATIONS  
1. Acute myocardial infarction (MI, within 2 days)  
2.  High risk Unstable angina 
3. Uncontrolled cardiac arrhythmia with hemodynamic compromise 
4. Acute endocarditis 
5. severe aortic stenosis 
6. Decomponsated  heart failure 
 7. Acute pulmonary embolus  
  8 .Acute aortic dissection  
  9 .Pulmonary infarction  
   10..Acute myocarditis    
  
  
     
.  
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RELATIVE CONTRAINDICATIONS  
1.  Known case of Left MCA stenosis  
2. Hypertrophic cardiomyopathy  with resting gradient. 
3. stenotic valvular heart disease   
4. Electrolyte imbalance  
4.” Severe arterial hypertension – In the absence of definite         
evidence,the committee suggests an SBP higher than 200         mm Hg, a 
DBP higher than 110 mm Hg, or both tachy         arrhythmias or brady 
arrhythmias”  
5. Outflow tract obstruction   
6. Mentally or physically  challenged  persons.  
7. High degree atrio ventricular (AV) block  
                “The vast majority of treadmill exercise tests are performed on 
adults with symptoms of known or probable ischemic heart disease.”  
  
TERMINATION  OF STRESS TESTING  
  
1.Moderate to severe angina  
2.Ataxia  
3.Dizziness  
4.Fall in  BP  
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5.Occurence  of cardiac arrhythmias especially ventricular   
 tachycardia Significant ST segment depression (>2 mm of      horizontal 
or downsloping  ST segment  
6. Development of LBBB or high degree of AV   
   Block or Increase in blood pressure more than 200 mm Hg  
7.Refusal of the patient to continue exercise  
  
BAYES THEOREM  
“States that the diagnostic power of exercise stress testing maximal 
when the pretest probability of CAD is intermediate  as indicated by age 
,sex and  nature of chest pain.”  
            After diagnosing  CAD  , a  previous myocardial infarction 
history and  clinical need for risk or prognostic assessment is required. To 
reach a decision regarding possible CAG or revascularization or  to guide  
medical management.  
  “ Myocardial infarction is the   first  presentation of  IHD and  
this subgroup  of patients  may require prognostic or risk assessment.”  
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METHODOLOGY OF EXERCISE TESTING 
  
There are three types of exercise modalities:  
(i) isotonic exercise or dynamic exercise  
(ii) isometric or static exercise,   
(iii) combination of the two forms of exercise.  
Commonly, it is the isotonic or dynamic exercise which is used for 
conducting the exercise test. This can be performed on a treadmill or a 
bicycle ergometer. Treadmill test involves greater muscle mass and hence 
achieves a greater level of oxygen uptake.   
By  this various dynamic protocols for conducting stress test have 
been enunciated. Some of them are Bruce, Naughton and Ellstead which 
are commonly used and, out of these, Bruce protocol is the one which is 
put to the maximum use. The protocol chosen for a particular patient 
should be such that it lasts for about 8 minutes to 12 minutes for 
continuous progressive exercise so that relevant information can be 
elucidated.  
The test involves testing the heart rate under the stress of exercise.  
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TECHNICAL CONSIDERATIONS 
  
In 1997 , the ACC/AHA guidelines for exercise tread mill testing 
were first developed.      
Basically   developed   to  form  recommendations for the  use of 
testing in the prognosis ,diagnosis, treatment,  and  of patients with  
probable or known coronary disease.  
               “ These guidelines were revised in 2002.”  
In  1997 guidelines, the available scientific evidence was not 
ranked as  level A, B, or C.  Later recommendations that appear  in the 
Update  
Highest Evidence  (A) is, if the study  are based on  randomized 
clinical trials  involving  huge  numbers of patients.  
         “An intermediate rank (B) indicates data derived from a limited 
number of randomized trials involving small numbers of patients. 
Analysed  from careful analyses of non randomized studies or 
observational registries”.  
          The lowest rank (C) indicates that the recommendation is primarily 
based on expert consensus.  
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Indications for exercise stress testing described in ACC/AHA 
guidelines ACC/AHA classes I, II, and III are used for categorization  
They include the following:  
“Class I – Conditions for  evidence and/or general agreement                    
exists that a given procedure or treatment is useful  and effective Class II  
– Conditions for which conflicting evidence and/or a                     
divergence of  opinion exists.”  
It  will show the  efficacy   or usefulness of a procedure or 
treatment. This class is further divided into subclasses IIa and IIb  
“Class IIa – The weight of opinion is in favour for                     
usefulness/efficacy.  Class IIb – Usefulness/efficacy is less established 
by evidence .   
Class III –Conditions for which evidence and/or general                     
agreement exists . The procedure/treatment is not  useful.  Some cases, 
may be   harmful”  
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SAFETY OF TREAD MILL TEST  
Exercise test is relatively a safe procedure with a high yield of    
diagnosis and  prognosis  in  patients of coronary artery diseases. By  a 
large number of experimental trails for 20 years ,it is estimated that there 
is one event per 10,000 patients. Despite the safety record of the test, it is 
essential to  that the test must be done in the presence of a trained 
professional and with all resuscitative measures at hand  
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COMPLICATION PREVENTION 
“Exercise testing is a  established procedure that has been in 
widespread clinical use for decades. Although it is generally safe, both 
myocardial infarction and death have been reported.  It can be expected 
to occur at a rate of 1  per 2500 tests. Therefore, we should have a good 
clinical judgment when deciding which patients should undergo exercise 
testing.”  
Things   needed  in establishing good clinical outcomes from 
exercise testing  are:  
1. “Quality, expertise, and experience of the professional and 
technical   staff   performing and interpreting the study .”  
2. The specificity sensitivity, and accuracy of the technique   
3. “The cost and accuracy of the technique as compared     with more 
expensive imaging procedures (to establish     the risk to benefit 
Ratio).   
4. “To determine the effect of positive or negative results on clinical 
decision making, and, to weigh the potential psychological 
benefits of patient reassurance”. 
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APPROACH TO ACS 
  
  
  
  
  
    
40 
 
ELECTRO CARDIOGRAPHIC CHANGES  
Normal  Electrocardiographic Changes During Exercise are 
recorded during TMT.  
The following changes in the electrocardiogram are observed while 
exercise in a normal adult:  
1. Increase in P wave amplitude  
2. PR shortening , shortening of  QRS and QT intervals with       
increasing heart    rate  
3. PR segment progressively becomes down-sloping in leads II,   
    III, aVF.     
 4 .It is  associated with this is the J point depression  
 
NORMAL ECG DURING TMT 
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 ABNORMAL RESPONSE  
It is predominantly the ST segment changes which are used to interpret 
the exercise test. The changes in ST segment can be:  
(i) No change in the ST segment  
(ii) Up sloping depression of ST segment  
(iii) Horizontal ST segment depression  
(Iv)  Down-sloping ST segment depression with T inversion  
(iv) ST segment elevation  
  
ECG  SHOWING  HORIZONTAL  ST  DEPRESSION 
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ECG  SHOWING  VERTICAL  ST  DEPRESSION  
  
  
  
PROGNOSIS  
Stress  test  has been  useful to provide information on prognosis: 
(i) Patients with CAD who have suffered a cardiac event or have 
undergone a cardiac intervention. 
(ii) Patients with valvular heart disease  
(iii)Patients with cardiac failure  
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EXERCISE    INDUCED    LBBB  
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CONCLUSION 
 
“Next to electrocardiogram , Exercise stress test is the second most 
commonly performed test. It is most important   complimentary test to 
medical history and physical examination. The evidence has clearly 
shown that interpretation of stress test using various treadmill scores (e.g. 
Duke Treadmill score) improves the diagnostic and prognostic capability 
of the test without escalating the cost.”  
A well-calibrated instrument and the performance of the test in an 
accurate manner is critical for  obtaining good results. The test should  be 
done with clearly defined indications  and it should be avoided strictly in 
presence of contraindications. In this particular test, it is of vital 
importance that the operator should be well versed when to terminate the  
 exercise test.    
The knowledge and the limitations in interpreting the test have to 
be understood and the result should be interpreted in a comprehensive 
manner using both the ECG and non-ECG criteria.   
 “The knowledge of the limitations in case of abnormal 
electrocardiogram at the beginning of the test has to be properly 
understood and rightly excluded. The use of diagnostic and prognostic 
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scores, such as Duke. Treadmill score, has increased the value of stress 
test very significantly ”  
 High Sensitivity C-Reactive Protein(HsCRP) 
A marker of systemic inflammation and  is  emerging as an 
independent risk factor for cardiovascular disease. High hsCRP levels 
have been attributed to the increased risk of thrombotic episodes 
including myocardial infarction.  
“C-reactive protein (CRP) is a member belonging to pentraxin 
family of proteins. It is an acute phase reactant and synthesized  by the 
liver. Serum  levels are elevated in a response to acute infections, 
inflammations and trauma. In those clinical situations, the serum CRP 
levels increase rapidly generally beyond 10 mg/l with a concomitant 
elevation of erythrocyte sedimentation rates (ESR)12. CRP has a 
relatively long half-life of 18 to 20 h, owing to its stable pentraxin 
structure. In addition, CRP levels are stable as these do not exhibit 
diurnal variations or variations in relation to food intake. In the past 
decade, high-sensitivity assays with rapid turnaround times for 
measurement have become available. High-sensitivity assay techniques 
such as immunonephelometry, immunoturbidimetry, high-sensitivity 
enzyme-linked immunosorbent assay (ELISA) and resonant acoustic 
profiling (RAP) can detect CRP with a sensitivity range of 0.01 to 10 mg/ 
l13. These high-sensitivity assays help quantify low grades of systemic 
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inflammation, in the absence of overt systemic inflammatory or 
immunologic disorders.”  
The hsCRP has been noted to have opsonizing properties, 
increasing the recruitment of monocytes into atheromatous plaque and 
also inducing endothelial dysfunction by suppressing basal and induced 
nitric oxide release. The hsCRP per se has also been found to increase 
the expression of vascular endothelial plasminogen activator inhibitor-1 
(PAI-1) and other adhesion molecules and alter LDL uptake by 
macrophages11. However, interventions that directly inhibit hsCRP would 
have to be evaluated before conclusively establishing hsCRP as a direct 
contributor to the atherosclerotic process. 
On the basis of data obtained from population based studies, the 
AHA/CDC (American Heart Association/Centres for Disease Control) 
Working Group on markers of inflammation in CVD has classified serum 
hsCRP levels <1, 1–3 and >3 mg/l as low-, intermediate-, and high-risk 
groups for global CVD, respectively. 
Elevated hsCRP levels have also been linked to an increased risk 
of future development of diabetes. Furthermore, hsCRP levels are 
increased in people with diabetes compared with those non diabetes. 
Studies have indicated that highly sensitive C-reactive protein (hsCRP) is 
an important biomarker for global cardiovascular risk prediction.  
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MATERIALS AND METHODS 
  
STUDY POPULATION  
 Study population 
    This study will be conducting on 100 patients with Type2 Diabetes 
patients visiting  Diabetology clinic during the study period at 
Government Rajaji, Hospital, Madurai. 
  
INCLUSION CRITERIA  
1.All Type 2 Diabetes patients as defined by ADA. 
2.Age  >40 yrs. 
3.Duration of Diabetes  >5yrs. 
4.Family history of CAD. 
5.Hypertenstion 
6.Dyslipidemia  
7.Current Tobacco smoking. 
8.BMI >23 kg/m2  
9.hsCRP  levels .  
10.Patients with normal ECG and Echocardiogram. 
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EXCLUSION CRITERIA  
1.Previous history of CAD/undergone coronary intervention. 
2.Patients with abnormal ECG and Echocardiogram suggestive of 
ischemia. 
3.Patient Refusal to give consent. 
4.Age <40 yrs. 
5.Recently discovered Diabetes and type 1 diabetes 
6.Severe valvular heart disease. 
7.Patients with chronic inflammatory condition.  
  
  
ANTICIPATED OUTCOME  
Screening of undiagnosed coronary artery disease in diabetes 
patients during asymptomatic period  and improving outcome by taking 
timely intervention.  
DATA COLLECTION  
        As per the  previously designed, profoma will be used to collect  
clinical information  of the samples and thorough clinical examination 
will be conducted. Electrocardiogram , Echocardiogram,  Excercise tread 
mill test will be done.  
The levels of high sensitivity c reactive protein will be measured 
and correlate the data.  
  
49 
 
 INVESTIGATIONS  
 1. Tread mill test(TMT) 
 2.Electrocardiogram 
 3.Echocardiogram 
 4.Fasting lipid profile 
 5.Fasting blood sugar 
 6.Post Prandial blood sugar 
 7.high sensitivity C-reactive protein.  
 8.serum Creatinine  
 9.complete urine analysis. 
  
  DESIGN OF STUDY  
       “  OBSERVATIONAL STUDY.”  
  
 PARTICIPANTS  
  100   patients attending   CARDIOLOGY and diabetology department    
   at  Govt  Rajaji hospital, Madurai .  
 PERIOD OF STUDY  
 6 months( JANUARY 2018 TO JUNE 2018)  
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COLLABORATING DEPARTMENTS  
   Department  of  DIABETOLGY 
   Department  of  CARDIOLOGY  
   Department  of  BIO CHEMISTRY  
ETHICAL CLEARANCE  
    Obtained  
CONSENT  
    Individual written and informed consent given.  
ANALYSIS  
   Statistical analysis.  
CONFLICT OF INTEREST  
    Nil  
FINANCIAL SUPPORT   
 Nil  
PARTICIPANTS  
    100  patients attending DIABETOLOGY AND CARDIOLOGY 
department at Govt  Rajaji hospital, Madurai.  
DATA COLLECTION  
The previously formulated proforma  used to collect the clinical 
and demographic details of the samples .Detailed history related to the 
present  as well as  a thorough history pertaining to other diseases were 
taken. .Each patient was enquired about previous drug history, coronary 
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artery disease,  hypertension ,diabetes and any other comorbid  
conditions.  
A  thorough   clinical test  and   biochemical investigations   were   
done  to  categorise   the patients  into  diabetic  with asymptomatic and 
associated risk factors for coronary artery disease . 
 An Electrocardiography was recorded   for  all  patients and they  
were subjected to Trans thoracic Echocardiography.  
Patients with  with  normal   ECG and ECHO will be undergoing to 
exercise treadmill test(TMT). 
   
LABORATORY EVALUATION  
• 1. Tread mill test(TMT) 
• 2.Electrocardiogram 
• 3.Echocardiogram 
• 4.Fasting lipid profile 
• 5.Fasting blood sugar 
• 6.Post Prandial blood sugar 
• 7.high sensitivity C-reactive protein.  
• 8.serum Creatinine  
• 9.complete urine analysis. 
  
  
52 
 
ELECTROCARDIOGRAPHY  
12 lead ECG was taken to all patients and screened for features 
suggestive of  any ischemia or infarction .  
ECHO CARDIOGRAPHY  
Transthoracic ECHOCARDIOGRAPHY was done for all patients. 
looked for  regional wall motion abnormalities .  
If patients with normal echocardiography will be segregated and will be 
subjected to  exercise  tread mill testing.   
HIGH SENSITIVITY C-REACTIVE PROTEIN 
Levels of High Sensitivity C-reactive protein will be measured in 
all patients who are subjected to tread mill testing  by immuno 
turbidometric method . 
HISTORY   
Thorough  history of   CAD, chest pain, breathlessness  easy 
fatiguibility  and syncopal attacks , previous  hospitalisation  have  
obtained.  
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STATISTICAL ANALYSIS 
The data collected in the study was formulated into master chart in 
Microsoft office excel  and  statistical analysis was done with the help of 
computer by using SPSS software and sigma stat 3.5 version(2012)  
Using  this software  standard  deviation,  mean ,  percentage   and  
p value were calculated through one  way ANOVA , PEARSON  
correlation and CHI SQUARE TEST and  P value of < 0.010  was taken 
as significant.  
  
RESULTS AND INTERPRETATION 
TABLE 1. AGE DISTRIBUTION OF STUDY POPULATION  
(n=100)  
  
AGE  
NO. OF 
CASES  
40-50 29 
51-60 51 
>60 20 
Total 100 
54 
 
   
Age group Positive Negative
40- 50 9 20 
51 - 60 14 37 
> 60 8 12 
Total 31 69 
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Correlation of tread mill test positivity with age. 
In our study mean age is 51.14 (+/_) 10 years with minimum age 
of 40 years. Maximum age of 65 years.  
 
COMMENTS  
1. 29% of cases between  40 to 50  years of age.    
2. 20%  of study population above  60 years of age.  
3. 51% of cases between 50- 60 years of age.  
4. Prevalence of CAD is increases  as age advances .  
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 TABLE 2.GENDER DISTRIBUTION OF STUDY POPULATION 
(n=100)  
 
SEX  NO OF CASES  
MALE 72 
FEMALE 28 
  
1. Majority of study population were males (72 %) 
2. while the remaining (28%) were females.  
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GENDER POSITIVE NEGATIVE 
Male 25 47 
Female 6 22 
Total 31 69 
P value 0.009 Significant 
 
 COMMENTS : 
1. Prevalence of cad in diabetes patients is most commonly affecting  the 
males   than females . 
2.  In this study 32  to 35% of the male  population positive for tread mill 
testing  and  is Found to have asymptomatic coronary artery disease and 
statistically significant. 
3.The  prevalence of CAD is about 6% in females .             
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 Table  3.  DISTRIBUTION OF DURATION OF DIABETES 
AMONG STUDY   POPULATION (100).  
  
DURATION 
OF  
DM (Yrs) 
NO.OF 
CASES 
<5 24 
5- 10 57 
>10 19 
 
Distribution of CAD risk among study population by TMT positivity 
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 Correlation of TMT positivity with duration of diabetes  
DURATION 
OF DM POSITIVE NEGATIVE 
< 5 8 16 
5- 10 17 40 
> 10 6 13 
Total 31 69 
 
COMMENTS  
1. Among the study population 24% of cases are having less than 5 years 
of duration of diabetes.  
2.19% of cases more than 10 years of duration of diabetes.  
3. 57% of cases between 5-10 years of duration of diabetes. 
4.The prevalence of asymptomatic CAD  33%  in the population group 
with duration of diabetes is  >10 yrs. 
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Table4 .Distribution of hypertension among study                     
population(100). 
 
HYPERTENSION YES NO 
Male 45 27 
Female 20 08 
Total 65 35 
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Distribution of hypertension vs CAD risk  among study population 
HYPERTENSION POSITIVE NEGATIVE 
Yes 29 13 
No 2 56 
Total 31 69 
P value <o.oo1 significant 
 
COMMENTS :.  
1. 65% of population group is hypertensive and majority of them 
are male  Population. 
2. The risk of CAD is 29% among the diabetics with hypertension 
which is  Statistically significant.               
3. Hence hypertension plays key risk factor for CAD in diabetes 
patients even though they are asymptomatic. 
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Table5. Distribution of smoking among study population 
  
SMOKING YES NO 
Male 40 32 
Female 0 28 
Total 40 60 
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Table.6. Distribution of smoking and CAD risk among study 
population  by TMT testing. TMT results. 
SMOKERS POSITIVE NEGATIVE 
Yes 23 10 
No 8 59 
Total 31 69 
P value 0.004 Significant 
 
COMMENTS : 
1. The major population of smoking among study population is males 
and the prevalence of coronary artery disease among smokers is 
65%.  
2. Hence the smoking plays an important risk factor for CAD in 
diabetic population  
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Table 7.Distribution of HsCRP among study population(100). 
The levels of hscrp has been measured all patients in the study group 
and compared with among the patients with TMT positive and TMT 
negative population. 
Hs-crp <3 mg/l >3 mg/l 
No of cases 69 31 
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Distribution hscrp mean vs CAD risk among study population  
CRP POSITIVE NEGATIVE
< 3 2 69 
> 3 29 0 
Mean 4.71 1.72 
SD 1.21 0.157 
p value < 0.001 Significant 
  
CRP Positive Negative
Mean 4.71 1.72 
 
 COMMENTS : 
1. The levels of hscrp is with value of >3 mg/l increased in   
patients with all cases of TMT positivity with mean value of 
4.71mg/l  and with standard deviation of 1.21 which is 
statistically significant. 
2. The levels of Hscrp in patients with TMT negativity is < 3mg/l 
with mean value of   1.76mg/l which is mild to moderate elevation.    
Hence the levels of hscrp of >3mg/l can be considered as supportive 
marker Of CAD in asymptomatic  type 2 diabetes patients and helps 
in prediction of future coronary event.   
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LIMITATIONS OF THE STUDY 
                                      
1. Sample size is small.  
2. The study population involved patients seeking medical care   in our 
hospital    which is a tertiary care center and hence they  may not 
represent the general population.  
3. Patients with osteo arthritis  and  any deformities in lower  limb  can 
not undergo exercise test.  
4. Patients may develop sudden MI during test.so keen  observation 
needed.  
5. ICU and good cardiac care must be available before doing   
TMT.Because any time patient may collapse.   
6.  It  is just a screening tool and further invasive procedure may be 
needed.    
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DISCUSSION 
The study was conducted in   patients who attended diabetology  
clinic, at Govt Rajaji hospital, Madurai. Diagnosis of Diabetes Mellitus  
was made  according to AMERICAN DIABETES ASSOCIATION 
,STANDARDS OF MEDICAL CARE IN DIABETES-2016 .CAD risk is 
assessed according to ACC/AHA  guidelines. Only newly diagnosed  
asymptomatic diabetic  patients are  taken in this study. After applying 
exclusion criteria 100 patients  are selected for study.  
 
          Out  of  100 patients 72 patients were male and 28 patients were  
female . It is consistent  with  previous clinical  studies because  nature of 
disease  is more commonly seen  in male when compared to females.  
 
Out of 100   patients 24 patients were 5 yrs or less than 5 years 
duration of diabetes, 57  patients were 5-10  years of duration of diabetes 
and 19 patients were >10  years duration of diabetes.  number of 
positivity  is high among the group  between  5-10 years duration of 
diabetes.  
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AK.Agarwal et al., have done similar study with 78 patients. but  
they divided  patients into two groups with  having non CAD group and 
CAD group. Among  them 28% (22 patients)  having subclinical  
ischemia in CAD group which is supported  by TMT positivity. But in 
our study   among 100 study  population patients are purely non CAD 
group that is ,asymptomatic and    31 patients(31%)having  silent 
ischemia  which is supported by TMT positivity alone, even though ECG 
and ECHO are showing no abnormalities.  
                     
   Mee Kyoung , Ki ho song et al. ,have conducted the  same study 
based on  parameter of duration of diabetes with 213 patients. They found 
that  Patients  with  more than 10 years of  duration of diabetes are  
having significant correlation of coronary artery  disease .Out of 213 
patients 42% found to have  positive treadmill test.  
                   
   In this study patients showing positive TMT even  with 5-10 years 
of duration which is consistent with that study and significant proportion 
of diabetics(31%) having silent ischemia which was detected by TMT .    
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     Mee Kyoung Kim has selected  the diabetics with  age more than 
60 and   in our study we have  taken  more than 40 years of age. so this 
study detecting ischemia young diabetics  than previous studies.  hence 
we can decrease  the diabetes related  mortality and morbidity and 
improve the quality of  life of diabetic patients.   
 
Won Sang Yoo et al .,  have conducted a study  with 115 diabetics  
.They are conducted the study with  2 groups :divided into group A(>2 
risk factor), group B with (<1 risk factor).   Patients are diagnosed  to 
have  diabetes by oral glucose tolerance test (OGTT) . TMT was done 
according to Bruce protocol using 12 lead ECG.  
  
This study found  that  Type 2 DM patients had a greater risk for 
CAD if they are older age group with longer  duration of diabetes And   
Positive family history of CVD even though they were asymptomatic. 
Based on these results they recommended that  TMT to be performed in 
order to detect CVD  in these asymptomatic group.  
 
But in our study ,we have conduted  patients with  risk  factors Like 
hypertension, smoking,   long duration of diabetes  and  age of patients 
and some patients with pure diabetics were selected and  subjected to 
TMT study.  
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   In our study we found out that prevalence of asymptomatic  CAD 
is more in patient group which is associated with cardiovascular risk 
factors such as hypertension, smokers  , long duration of diabetes ,male 
gender and advanced age.                   
 
Hae chong geong et.al.,conducted study with 445 diabetes patients 
with for detection of subclinical atherosclerosis patients using 
TMT,MDCT and HsCRp and found that prevalence of CAD in that group 
is 49% and the all the patients with TMT positivity are having the hscrp 
levels of 1+_7 mg/l . 
 
In our study we have measured the hscrp levels in all 100 diabetes 
patients without any symptoms of CAD and finally found that the levls of 
hscrp elevated with reference range of >3 mg/l in those patients with 
TMT positivity. 
 
Hence this study concludes that levels of Hscrp is elevated in type 
2 diabetes patients with underlying CAD even though they are clinically 
asymptomatic and this can be used as supportive marker for detection of 
underlying CAD in patients with type2 diabetes.   
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SUMMARY 
  
This    observational  prospective study was performed to identify 
the prevalence of  asymptomatic  atherosclerotic coronary artery disease 
in type 2 diabetes patients  by using tread mill test as a screening tool and 
high sensitivity c-reactive protein as supportive  marker. 
 
100  patients  were selected  and they  were  evaluated  on clinical 
and  laboratory  parameters  after getting clearance from   an institutional 
ethical committe with an informed  consent. The data were  entered  in  
Microsoft  Excel spread  sheet   and analysed  statistically.  
 
Prevalence    of  inducible ischemia is commonly seen  in type 2 
diabetes  patients  with associated cardiovascular risk factors even in the 
absence of symptoms and its incidence is high in patients with 
hypertension, smokers,  and long duration of diabetes more than 5 to 10 
years and advanced age and the  levels of high sensitivity c-reactive 
protein  is elevated in with range of  >3 to 7 mg/l. 
 
The risk is  significantly   high as duration of diabetes increases and 
since diabetes mellitus is a coronary equalent ,Strict glycemic control  
and duration  of  disease is found to play  important key factors in the  
prevalence   of coronary  artery  disease in these  patients.  
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CONCLUSION 
  
Early detection  of  asymptomatic coronary artery disease in  type 
2 diabetes mellitus has got paramount importance since CAD responsible 
for high mortality and morbidity. 
TREAD MILL TESTING can be used as significant tool for 
detection of underlying CAD and  it is supported by levels of HIGH 
SENSITIVITY C REACTIVE PROTEIN as surrogative marker . 
The early introduction of medical intervention  will reduce the  
disease related morbidity and mortality significantly.  
           By controlling  hypertension, cessation of smoking ,strict control 
blood sugar and  avoidance  of  physical inactivity    can reduce risk of 
CAD.  
         By all these measures we can improve long term survival of 
diabetic  patients by timely intervention and follow up.   
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PROFORMA 
  
Name:  
Age / Sex:  
Occupation:  
Presenting complaints  
 H/o chest pain  
 H/o sweating  
 H/o breathlessness  
 H/o epigastric pain  
 H/o breathing difficulty  
 H/o vomiting  
 H/o abdominal pain  
 H/o polyuria  
 H/o polydipsia  
 H/o polyphagia  
Past History:  
H/o PT  
 H/o HT  
 H/o CAD  
 H/o CKD  
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 H/o PHERIPHERAL VASCULAR DISEASE  
 H/o ENDOCRINOPATHIES  
 H/o DRUG INTAKE  
Clinical Examination:  
General Examination:  
Consciousness  
Pallor  
Jaundice  
Clubbing  
Lymphadenopathy  
Pedal edema.  
Vitals:  
PR  
BP  
RR  
Weight / height:  
Systemic examination:  
CVS:  
RS:  
ABDOMEN:  
CNS:  
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Laboratory investigations:  
CBC 
ESR  
RFT  
RANDOM BLOOD GLUCOSE  
FASTING PLASMA GLUCOSE  
POST PRANDIAL BLOOD GLUCOSE.  
FASTING LIPID PROFILE  
HIGH SENSITIVITY C-REACTIVE PROTEIN 
URINE ANALYSIS 
ELECTROCARDIOGRAPHY 
ECHOCARDIOGRAPHY 
TREAD MILL TESTING. 
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LIST OF ABBREVATIONS 
  
DM               -DIABETES MELLITUS  
MODY         -MATURITY ONSET DIABETES OF YOUNG  
BMI              -BODY MASS INDEX  
PCOS            -POLYCYSTIC OVARIAN SYNDROME  
HDL              -HIGH DENSITY CHOLESTEROL  
GDM             -GESTATIONAL DIABETES MELLITUS  
IFG                -IMPAIRED FASTING GLUCOSE  
IGT                -IMPAIRED GLUCOSE TOLERANCE  
ASCVD         -ATHEROSCLEROTIC CARDIO VASCULAR DISEASE  
DKA              -DIABETIC KETO ACIDOSIS  
CAD         -CORONARY ARTERY DISEASE SHT         
 SHTN-          SYSTEMIC HYPERTENSION  
LDL               -LOW DENSITY CHOLESTEROL  
VLDL            -VERY LOW DENSITY CHOLESTEROL  
NIDDM         -NON INSULIN DEPENDENT DIABETES MELLITUS  
ADA              -AMERICAN DIABETES ASSOCIATION  
OGTT            -ORAL GLUCOSE TOLERANCE TEST  
DCCT            -DIABETES CONTROL&COMPLICATIONS TRIAL  
PVD               -PERIPHERAL VASCULAR DISEASE  
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ACR               -ALBUMIN CREATININE RATIO  
PCWP            -PULMONARY CAPILLARY WEDGE PRESSURE  
MET            -METABOLIC EQUIALENT  
CABG         -CORONARY ARTERY BYEPASS GRAFT  
AHA            -AMERICAN HEART ASSOCIATION  
 IR                -INSULIN RESISTANCE  
MI                -MYOCARDIAL INFARCTION  
FBS              -FASTING BLOOD SUGAR  
PPBS            -POST PRANDIAL BLOOD SUGAR  
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MASTER CHART   
S.No Age Sex HTN Smokers Duration(Yrs) CRP(mg/l) TMT 
Results 
1 45 Female YES NO 8 3.5 Positive 
2 55 Female NO NO 10 5.6 Positive 
3 45 Female YES NO 8 3.8 Positive 
4 60 Female YES NO 15 3.9 Positive 
5 62 Female YES NO 10 4.8 Positive 
6 48 Male YES YES 5 6.1 Positive 
7 52 Male YES YES 8 3.8 Positive 
8 60 Male YES NO 10 5.2 Positive 
9 45 Male YES YES 5 3.9 Positive 
10 46 Male YES NO 5 4.8 Positive 
11 55 Male YES YES 10 5.6 Positive 
12 54 Male YES YES 10 5.2 Positive 
13 62 Male YES YES 15 5.8 Positive 
14 61 Male YES YES 10 3.8 Positive 
15 48 Male YES YES 8 4.8 Positive 
16 60 Male YES YES 10 5.8 Positive 
17 63 Male YES YES 15 5.2 Positive 
18 49 Male YES YES 10 3.2 Positive 
19 55 Male YES YES 8 4.5 Positive 
20 60 Male YES YES 8 4.8 Positive 
21 56 Male YES NO 5 3.5 Positive 
85 
 
22 48 Male YES NO 6 3.1 Positive 
23 52 Male YES YES 5 2.9 Positive 
24 61 Male YES YES 11 5.8 Positive 
25 60 Male YES YES 8 8.0 Positive 
26 50 Male YES YES 5 6.2 Positive 
27 61 Male YES YES 5 2.9 Positive 
28 64 Male NO YES 5 3.2 Positive 
29 60 Male YES YES 11 5.2 Positive 
30 65 Male YES YES 10 5.0 Positive 
31 52 Male YES YES 12 6.1 Positive 
32 43 Female NO NO 8 1.6 Negative 
33 45 Female YES NO 5 2.0 Negative 
34 42 Female YES NO 8 1.9 Negative 
35 40 Female NO NO 5 1.8 Negative 
36 45 Female NO NO 5 1.7 Negative 
37 40 Male NO YES 10 1.6 Negative 
38 42 Male NO NO 5 1.7 Negative 
39 43 Male NO NO 8 1.9 Negative 
40 49 Male NO NO 8 1.5 Negative 
41 46 Female NO NO 3 1.7 Negative 
42 55 Female YES NO 5 1.9 Negative 
43 50 Male NO NO 10 1.6 Negative 
44 55 Female YES NO 5 1.7 Negative 
45 55 Male NO NO 8 1.9 Negative 
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46 55 Female YES NO 10 1.6 Negative 
47 55 Male NO NO 5 1.6 Negative 
48 54 Male NO YES 5 1.5 Negative 
49 57 Male NO YES 7 1.7 Negative 
50 53 Male NO NO 6 1.6 Negative 
51 58 Female YES NO 10 1.7 Negative 
52 62 Male NO YES 8 1.9 Negative 
53 63 Male NO NO 5 1.7 Negative 
54 62 Male NO NO 9 1.7 Negative 
55 62 Male NO NO 10 1.6 Negative 
56 65 Male NO NO 8 1.6 Negative 
57 61 Male NO NO 5 1.9 Negative 
58 64 Male NO NO 9 1.5 Negative 
59 65 Female YES NO 12 1.7 Negative 
60 60 Female NO NO 8 1.9 Negative 
61 59 Female NO NO 10 1.6 Negative 
62 52 Female NO NO 8 1.9 Negative 
63 58 Female NO NO 10 1.6 Negative 
64 60 Male NO NO 12 1.5 Negative 
65 48 Male NO YES 7 1.7 Negative 
66 62 Male NO NO 10 1.6 Negative 
67 48 Male NO NO 8 2.0 Negative 
68 52 Female YES NO 6 1.9 Negative 
69 60 Female NO NO 10 1.6 Negative 
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70 60 Male NO NO 12 1.7 Negative 
71 62 Male NO NO 10 1.5 Negative 
72 48 Female NO NO 15 1.7 Negative 
73 52 Male NO NO 10 1.7 Negative 
74 60 Male NO YES 5 1.6 Negative 
75 55 Female NO NO 5 1.7 Negative 
76 60 Male NO NO 10 2.0 Negative 
77 56 Male NO NO 10 1.9 Negative 
78 48 Female NO NO 12 1.5 Negative 
79 50 Male YES NO 7 1.7 Negative 
80 58 Male NO YES 10 1.6 Negative 
81 60 Female NO NO 5 2.0 Negative 
82 58 Male YES YES 7 2.1 Negative 
83 60 Male YES NO 10 1.8 Negative 
84 48 Male NO NO 5 1.7 Negative 
85 62 Male NO NO 11 1.6 Negative 
86 48 Male NO NO 8 1.7 Negative 
87 52 Male NO NO 12 1.9 Negative 
88 60 Male NO NO 10 1.5 Negative 
89 60 Male NO YES 8 1.7 Negative 
90 62 Male NO NO 6 1.9 Negative 
91 48 Male YES NO 11 1.6 Negative 
92 52 Male NO NO 8 1.7 Negative 
93 60 Male YES NO 5 1.9 Negative 
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94 55 Male NO NO 11 1.6 Negative 
95 60 Male NO NO 12 1.6 Negative 
96 56 Male NO NO 8 1.7 Negative 
97 48 Male NO NO 15 1.9 Negative 
98 52 Female NO YES 12 1.6 Negative 
99 58 Male NO NO 8 1.4 Negative 
100 60 Male NO NO 10 1.9 Negative 
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